Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS.

McMahon M, Contreras A, Holm M, Uechi T, Forester CM, Pang X, Jackson C, Calvert ME, Chen B, Quigley DA, Luk JM, Kelley RK, Gordan JD, Gill RM, Blanchard SC, Ruggero D.

Elife. 2019 Sep 3;8. pii: e48847. doi: 10.7554/eLife.48847.

2.

TASP1 mutation in a female with craniofacial anomalies, anterior segment dysgenesis, congenital immunodeficiency and macrocytic anemia.

Balkin DM, Poranki M, Forester CM, Dorsey MJ, Slavotinek A, Pomerantz JH.

Mol Genet Genomic Med. 2019 Sep;7(9):e818. doi: 10.1002/mgg3.818. Epub 2019 Jul 27.

3.

Translation control of the immune checkpoint in cancer and its therapeutic targeting.

Xu Y, Poggio M, Jin HY, Shi Z, Forester CM, Wang Y, Stumpf CR, Xue L, Devericks E, So L, Nguyen HG, Griselin A, Gordan JD, Umetsu SE, Reich SH, Worland ST, Asthana S, Barna M, Webster KR, Cunningham JT, Ruggero D.

Nat Med. 2019 Feb;25(2):301-311. doi: 10.1038/s41591-018-0321-2. Epub 2019 Jan 14.

4.

Transfusion practices and complications in thalassemia.

Lal A, Wong TE, Andrews J, Balasa VV, Chung JH, Forester CM, Ikeda AK, Keel SB, Pagano MB, Puthenveetil G, Shah SJ, Yu JC, Vichinsky EP.

Transfusion. 2018 Dec;58(12):2826-2835. doi: 10.1111/trf.14875. Epub 2018 Sep 27.

PMID:
30260477
5.

Development of a stress response therapy targeting aggressive prostate cancer.

Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D.

Sci Transl Med. 2018 May 2;10(439). pii: eaar2036. doi: 10.1126/scitranslmed.aar2036.

6.

Revealing nascent proteomics in signaling pathways and cell differentiation.

Forester CM, Zhao Q, Phillips NJ, Urisman A, Chalkley RJ, Oses-Prieto JA, Zhang L, Ruggero D, Burlingame AL.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2353-2358. doi: 10.1073/pnas.1707514115. Epub 2018 Feb 21.

7.

EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.

Huang X, He Y, Dubuc AM, Hashizume R, Zhang W, Reimand J, Yang H, Wang TA, Stehbens SJ, Younger S, Barshow S, Zhu S, Cooper MK, Peacock J, Ramaswamy V, Garzia L, Wu X, Remke M, Forester CM, Kim CC, Weiss WA, James CD, Shuman MA, Bader GD, Mueller S, Taylor MD, Jan YN, Jan LY.

Nat Neurosci. 2015 Sep;18(9):1236-46. doi: 10.1038/nn.4088. Epub 2015 Aug 10.

8.

Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors.

Forester CM, Sartain SE, Guo D, Harris MH, Weinberg OK, Fleming MD, London WB, Williams DA, Hofmann I.

Am J Hematol. 2015 Apr;90(4):320-6. doi: 10.1002/ajh.23937. Epub 2015 Mar 2.

9.

Skin lesions and lung cysts in a neonate.

Forester CM, Terry J, Lee EY, Simoneau T, Haver K.

J Pediatr. 2012 Jun;160(6):1061-1.e1. doi: 10.1016/j.jpeds.2012.01.048. Epub 2012 Mar 7. No abstract available.

PMID:
22404953
10.

Tumefactive intracranial presentation of precursor B-cell acute lymphoblastic leukemia.

Forester CM, Braunreiter CL, Yaish H, Hedlund GL, Afify Z.

Pediatr Radiol. 2009 Nov;39(11):1230-3. doi: 10.1007/s00247-009-1347-x. Epub 2009 Sep 10.

PMID:
19763560
11.

Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1.

Forester CM, Maddox J, Louis JV, Goris J, Virshup DM.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19867-72. Epub 2007 Dec 4.

12.

Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis.

Margolis SS, Perry JA, Forester CM, Nutt LK, Guo Y, Jardim MJ, Thomenius MJ, Freel CD, Darbandi R, Ahn JH, Arroyo JD, Wang XF, Shenolikar S, Nairn AC, Dunphy WG, Hahn WC, Virshup DM, Kornbluth S.

Cell. 2006 Nov 17;127(4):759-73.

13.

Rat cytomegalovirus major immediate-early enhancer switching results in altered growth characteristics.

Sandford GR, Brock LE, Voigt S, Forester CM, Burns WH.

J Virol. 2001 Jun;75(11):5076-83.

Supplemental Content

Loading ...
Support Center